login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
VERACYTE INC (VCYT) Stock News
NASDAQ:VCYT -
US92337F1075
-
Common Stock
30.11
USD
-0.23 (-0.76%)
Last: 9/2/2025, 6:41:02 PM
30.28
USD
+0.17 (+0.56%)
After Hours:
9/2/2025, 6:41:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VCYT Latest News, Press Relases and Analysis
All
Press Releases
21 days ago - By: Chartmill
Veracyte Inc (NASDAQ:VCYT) Emerges as a Strong Value Pick with Solid Fundamentals and Growth Potential
a day ago - By: Zacks Investment Research
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
4 days ago - By: Zacks Investment Research
Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today
4 days ago - By: Veracyte, Inc.
Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
6 days ago - By: Veracyte, Inc.
Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
7 days ago - By: Zacks Investment Research
- Mentions:
NEO
TEM
Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership
7 days ago - By: Veracyte, Inc.
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test
11 days ago - By: Zacks Investment Research
Here's Why Veracyte (VCYT) is a Strong Momentum Stock
18 days ago - By: Zacks Investment Research
Here's Why Veracyte (VCYT) is a Strong Growth Stock
21 days ago - By: Zacks Investment Research
- Mentions:
CAH
MEDP
WGS
VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up
a month ago - By: The Motley Fool
Veracyte (VCYT) Q2 Revenue Jumps 14%
a month ago - By: Zacks Investment Research
- Mentions:
SGHT
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates
a month ago - By: Veracyte, Inc.
Veracyte Announces Second Quarter 2025 Financial Results
a month ago - By: Benzinga
- Mentions:
OEC
VTLE
DIN
INSE
...
Earnings Scheduled For August 6, 2025
a month ago - By: Yahoo Finance
Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion
2 months ago - By: Veracyte, Inc.
Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025
2 months ago - By: Veracyte, Inc.
Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025
2 months ago - By: Zacks Investment Research
- Mentions:
MYGN
TEM
Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches
3 months ago - By: Yahoo Finance
- Mentions:
TSLA
PLTR
ARKK
AMD
...
Cathie Wood sells $22.8 million of hot stock near all-time highs
3 months ago - By: Yahoo Finance
- Mentions:
ENB
IART
NEM
DOW
...
Enbridge Is One of the Largest Energy Companies by Market Cap. But Is It a Buy?
3 months ago - By: Zacks Investment Research
- Mentions:
IART
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
3 months ago - By: Yahoo Finance
- Mentions:
REGN
TBIO
SCYX
PEPG
...
Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency
3 months ago - By: Veracyte, Inc.
Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
4 months ago - By: Veracyte, Inc.
Veracyte to Participate in Upcoming Investor Conferences
4 months ago - By: Zacks Investment Research
- Mentions:
CAH
STE
PAHC
Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?
4 months ago - By: Yahoo Finance
- Mentions:
RXRX
NVDA
PRTA
ROG
...
Why Recursion Pharmaceuticals Stock Plummeted 24% This Week
4 months ago - By: Zacks Investment Research
- Mentions:
BSX
ANGO
ITGR
Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up
4 months ago - By: Yahoo Finance
- Mentions:
FIS
Should I Take Money Out of My Roth IRA To Pay My Debt? Experts Weigh In
4 months ago - By: Zacks Investment Research
What Makes Veracyte (VCYT) a New Buy Stock
4 months ago - By: Benzinga
Breaking Down Veracyte: 7 Analysts Share Their Views
4 months ago - By: Zacks Investment Research
- Mentions:
TMCI
Veracyte (VCYT) Q1 Earnings and Revenues Beat Estimates
4 months ago - By: Veracyte, Inc.
Veracyte Announces First Quarter 2025 Financial Results
4 months ago - By: Zacks Investment Research
- Mentions:
EKSO
Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates
Please enable JavaScript to continue using this application.